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Accepted 19 January 2012AbstractObjective: Perimenopausal women are at high risk for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) diseases. In the present
study, the expression of VIP in the vaginal epithelium of 70 perimenopausal women was correlated with the severity of POP with or without SUI.
Materials and Methods: Seventy biopsy specimens from the anterior vaginal epithelium were obtained from postmenopausal patients. Immu-
nohistochemical labeling for vasoactive intestinal peptide (VIP) and hematoxylin and eosin staining were performed. The VIP innervation was
then compared between eight patient groups. Semiquantitative analysis of VIP protein by Western blotting was performed and compared be-
tween the eight patient groups.
Results: The results of the immunohistochemical study showed that the intensity of VIP-immunoreactivity (VIP-ir) in the eight groups was as
follows (in decreasing order): Control; POPI; POP II; POP II þ SUI; POP III; POP IV and POP III þ SUI; and POP IV þ SUI. The intensity of
VIP-ir was obviously weak and similar among the POP IV, POP III þ SUI, and POP IV þ SUI groups. This result was validated by the Western
blotting analysis. The level of the VIP peptide also deceased in POP patients and was as follows (in decreasing order): Control; POPI; POP II and
POP II þ SUI; POP III and POP III þ SUI; and POP IV and POP IV þ SUI.
Conclusion: The present study found that reduced VIP innervation in the vaginal epithelium of the perimenopausal women was correlated with
the severity of POP with or without SUI.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Pelvic organ prolapse (POP) is frequently encountered in
middle-aged and elderly women, and approximately one of
every nine women will undergo surgery to correct POP and
associated bladder and bowel dysfunction [1]. Stress urinary
incontinence (SUI) is another pelvic dysfunction disease with
an etiology similar to that of POP [2]. In general, POP is a
major problem associated with altered anatomy of the pelvic
floor. It may be caused by direct injury to the levator ani (LA)* Corresponding author. Department of Anatomy, Zhong Shan School of
Medicine, Sun Yat-Sen University, Number 74 Zhongshan Road 2, Guangzhou
510080, China.
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http://dx.doi.org/10.1016/j.tjog.2013.04.014muscle, denervation of the pelvic floor musculature, or fascial
damage incurred during traumatic childbirth [3,4]. Repro-
ductive functions are under the influence of a peptidergic
component of the parasympathetic and sympathetic branches
of the autonomic nervous system [5]. Vasoactive intestinal
peptide (VIP)-containing nerves have been described
throughout the human female genital tract and are most
abundant in the vagina, cervix, and clitoris [6,7]. Therefore,
we hypothesized that VIP secreted by neuropeptidergic fiber
terminals parties involved in the pathogenesis of POP. To
explore the relationship between VIP innervation and the de-
gree of POP, in the present study we tested for changes in VIP
innervation in the epithelium of the anterior vaginal wall in
patients with POP.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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years (age range, 30e70 years) and were treated at the
Department of Obstetrics and Gynecology of the Guangdong
General Hospital between August 2008 and June 2009.
Following gynecologic examinations, the patients were
divided into four groups in accordance with the Pelvic Organ
Prolapse Quantification (POP-Q) system [8]. There were 15
patients in POP I, 16 patients in POP II, 14 patients in POP III,
and 15 patients in POP IV. Stress urinary incontinence was
diagnosed by patient history, gynecologic examination, pad
test, and urodynamic examination in accordance with the In-
ternational Continent Society Standard [7]. Eleven patients in
POP II, 6 patients in POP III, and 9 patients in POP IV had
accompanying SUI, which placed them in the POP II þ SUI,
POP III þ SUI and POP IV þ SUI groups, respectively. Nine
patients with benign gynecological conditions but no history
of POP or SUI were placed in the control group. The study
was approved by the Hospital Scientific Committee. All pa-
tients consented to participate in the clinical trial and agreed to
have biopsies performed.Tissue extractionFor consistency, 70 biopsy specimens of the midline ante-
rior vaginal cuff were obtained from 70 patients undergoing
intravaginal panhysterectomy, anterior/posterior colporrhaphy,
and pelvic floor function reconstruction. None of the patients
took hormonal drugs during the 3 months before surgery.
Excluded from the study were women who had previous
endometriosis, adenomyosis, uterine fibroids, connective tis-
sue disorders, pelvic inflammatory conditions, or pelvic
surgery.Sample preparationAfter rinsing with saline to remove remaining blood,
samples 3-mm to 5-mm thick and measuring 100e300 mg
were obtained from each specimen. Half of each sample was
placed in 10% formalin for VIP immunohistochemistry (IHC)
and routine hematoxylin-eosin (HE) staining. The other half
was prepared for Western blotting (WB) analysis. Formalin-
fixed specimens were embedded in paraffin, sectioned
(3 mm), and fixed to glass slides. Paraffin sections were
deparaffinized, rehydrated with xylene and a graded series of
ethyl alcohol, and rinsed with phosphate-buffered saline (PBS)
three times.Hematoxylin-eosin stainingHematoxylin-eosin staining was performed in accordance
with standard protocols for examination for routine light
microscopy.Immunohistochemistry for VIPImmunohistochemistry procedures were performed ac-
cording to our previous studies [9e12]. The slides were boiled
in 0.01 mol/L sodium citrate buffer (pH 6.0) for 15 minutes in a
microwave oven. Sections were washed three times with
0.01 M PBS for 10 minutes, incubated in 3% peroxide in
methanol at room temperature for 20 minutes to quench
endogenous peroxidase activity, and then rinsed three times
with PBS. The sections were then incubated in 2% bovine
serum albumin (BSA) and 0.2% Triton X-100 in 0.01 M PBS at
room temperature for 1 hour, followed by incubation overnight
with mouse anti-VIP antibody (1:100; Santa Cruz Biotech-
nology, Dallas, Texas, USA). After washing with PBS, bio-
tinylated anti-mouse IgG antibody (1:200; Gene Tech,
Shanghai Company Limited, China) was added to the sections
and incubated at room temperature for 35 minutes. The primary
or secondary antibody and the tissue sample were replaced with
PBS as the negative control and with small intestine as the
positive. The VIP was visualized with 3,3-diaminobenzidine
(Sigma, Saint Louis, MO, USA) as the chromogen. The slides
were rinsed with distilled water and counterstained with HE.Semi-quantitative analysis of VIP immunoreactivityImages were acquired with a camera mounted on an
Olympus microscope (Carl Zeiss, Germany) using 10, 40,
and 100 objective lenses. Under a microscope using a 40
lens or a 100 lens, VIP-immunoreactive (VIP-ir) particles
were counted, if necessary, by two independent observers. The
evaluation of immunoreactivity was semiquantitatively
assessed, based on staining intensity and distribution. A four-
point ordinate scale was adopted, based on previous studies
[5,7,13]. Estimation of VIP nerve supply was graded by VIP-ir
staining, as follows: “þþþ” indicates a dense supply (i.e.,
showing strong brown staining with a ring-like distribution);
“þþ” indicates a moderate supply (i.e., showing brown
staining with concentrated distribution); “þ” indicates a scarce
supply (i.e., showing weak brown staining with sparse distri-
bution); and “e” indicates no detectable immunoreactivity.Western blotting analysisThe procedures of the WB in this study were similar to the
procedure used in our previous studies [14]. Using a grinder by
hand, the vaginal tissues were homogenized in radio immuno-
precipitation assay (RIPA) buffer supplemented with protease
inhibitor cocktail and 1mM phenylmethanesulfonyl fluoride
(PMSF). The homogenates were lysed in ice for 1 hour, and then
centrifuged at 15,000 r.p.m. for 30 minutes at 4 C. The su-
pernatant was decanted. The protein concentration was deter-
mined by using the Bio-Rad protein assay kit (Bio-Rad,
Hercules, CA, USA). Equal amounts of protein were loaded and
separated by electrophoresis on 10% sodium dodecyl sulfate
(SDS)-polyacrylamide gels. Proteins were transferred onto a
polyvinylidene difluoride membrane (Millipore, Bedford,MA).
The membranes were then blocked for 1 hour at room
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followed by overnight incubation at 4 C with the mouse anti-
VIP (1:1000). The membranes were washed three times in
tris-buffered saline and tween 20 and incubated for 2 hours at
room temperature with anti-mouse IgG (1:4,000, Amersham
Biosciences, Piscataway, NJ), and then detected by electro-
chemiluminescence (Pierce, Rockford, IL, USA). The same
membrane was stripped and reblotted with a mouse anti-b-actin
antibody (1:1000; Boster, China) for normalization. The blots
were exposed to X-ray film (FUJIFILM, Japan). All studies
were performed a minimum of five times, using independent
samples from different groups. The changes of the VIP protein
levels ratio, corresponding to b-actin level, were determined by
the optical density measurements on Western immunoblot. The
relative levels of proteins in the different lanes were compared
by analyzing scanned images using the NIH IMAGE program
(National Institutes of Health, MA, USA). The intensity was
quantified by the corresponding b-actin.Statistical analysisStatistical calculations and data handling were performed
using SPSS version 16.0 (Statistical Product and Service So-
lutions, LA, USA) by two persons who were blinded to the
different groups. All data for continuous variables were
expressed as the mean  standard deviation (X  SD) along
with ranges. The Kruskal-Wallis test was applied to detect
differences among groups for ranked data [7,9]. Semi-
quantitative changes in the VIP level relative to the b-actin level
in the POP groups were determined by optical density mea-
surements. Data are shown as the mean  SD (n ¼ 3 indepen-
dent blots from 3 separate experiments) and expressed as the
fold changes in comparison to the controls. One-way analysis of
variance (ANOVA) with a Bonferroni post-hoc multiple com-
parisons test was applied to detect differences between the
groups. The null hypothesis was rejected at p < 0.05.
ResultsGeneral conditions of the studied patientsAge, number of postmenopausal years, SUI complications,
parity, and body mass index (BMI, calculated as weight in ki-
lograms divided by height in meters squared) were compared
across the four groups of POP patients and the control group
(Table 1). The F values for these data were estimated by theTable 1
General conditions of the patients.
Group Case Age Menopausa
y, (mean  SD) n (%)
Control 10 57.34  4.26 2 (20%)
POP I 15 59.76  7.23 12 (80%)
POP II 16 60.26  6.55 14 (88%)
POP III 14 63.35  7.86 14 (100%)
POPIV 15 61.50  8.98 13 (87%)
BMI ¼ body-mass index; POP ¼ pelvic organ prolapse; SD ¼ standard deviationKruskal-Wallis test. For each comparison, p was greater than
0.05, suggesting that differences in age, BMI, parity, and years
post menopause were not significant between the four POP
groups and the control group. Thus, the study groups were
similar and comparable with regard to these factors.Histology of the anterior vaginal wall of POP patientsFig. 1 shows the HE-stained microphotos that characterize
the morphologic appearance of the anterior vaginal wall of
POP patients. Three layers were identified across the vaginal
wall under light microscopy: the mucous layer, the muscular
layer, and the fibrous tissue membrane layer. The vaginal
mucosa consisted of squamous epithelium and the underlying
lamina propria. The remaining vaginal wall (approximately
70e75% of the total wall thickness) consisted of the muscu-
laris layer and the adventitia. Smooth muscle, small blood
vessels, capillaries, and nervous tissue were situated in the
lamina propria, which was principally composed of connective
tissue (Fig. 1A). The muscularis contained superficial and
deep layers demarcated by changes in muscle orientation or by
a layer of perforating vessels. In the control group, the smooth
muscles were thick and well arranged like a braid and without
fissures in the muscle fibers (Fig. 1A). In POP I, the connective
tissues remained neat and compact, but local alterations in
density were apparent. Small vessels and capillaries were
abundant and their walls demonstrated thinning (Fig. 1B). In
POP II, the epithelium appeared to vary in thickness, and the
connective tissue was not as organized. The number of blood
vessels and the number of cells in vessel walls were both
reduced (Fig. 1C). The muscularis and muscle bundles from
POP III and POP IV women were poorly organized, with the
collagen fibers loosely dispersed throughout (Fig. 1D and E).
The vessel wall was thin with poor elasticity and with clot
deposition (Fig. 1E). In women with POP þ SUI, the lamina
propria tissue was more loosely dispersed and disorganized
(Fig. 1FeH) than in patients with POP without SUI. In POP
IV þ SUI, some of the lamina propria tissue was broken down
and the number of cells was decreased (Fig. 1H).VIP innervation in the anterior vaginal wall of POP
patientsThe VIP immunoreactivity in the subepithelial connective
tissue of the vaginal epithelium in all control and POP groups
was measured. Fig. 2 shows results. The VIP-ir was detectedl With SUI Parity BMI (kg/m2)
n (%) Mean  SD
0 (0%) 1.32  0.34 22.74  2.09
0 (0%) 2.20  0.83 24.29  2.03
11 (69%) 2.41  0.85 21.16  2.07
6 (43%) 2.67  1.26 23.08  2.05
9 (60%) 3.34  1.32 22.92  2.41
; SUI ¼ stress urinary incontinence.
Fig. 1. Histologic features of the anterior vaginal wall from an asymptomatic control and from patients with pelvic organ prolapse (POP) with or without stress urinary
incontinence (SUI). (A) In the control group, the tissue structures in the vaginal wall cross-sections arewell-arranged and tight as a braid without breakage. (B) In POP
I, the connective tissues were still neat and compact, but locally have an uneven density, abundant small vessels and capillaries, and their wall is thinning. (C) In POP
II, the epithelium has variable thickness and the connective tissues are not neat. The tissue is obviously more areolar and the number of blood vessels and cells in the
wall are reduced. (D) In POP III, the lamina propria tissue has a loose arrangement, the smooth muscle is disarranged in varying degrees, and the gaps are loose. (E) In
POP IV, the lamina propria tissue is disarranged, gaps are obvious and tissue breakdown is apparent, the vessel wall is thin and has less elasticity and clot disposition.
(F) In the POP IIþ SUI group, the lamina propria tissues are looser and the gaps are more obvious in comparison to the POP II group. (G) In the POP IIIþ SUI group,
the lamina propria tissue is loose, disarranged, and shows significant breakdown. (H) In the POP IV þ SUI group, the lamina propria tissue is in great disorder and
shows breakdown, and the number of cells is decreased. (The scale bar ¼ 100 mm. Hematoxylin-eosin stain used in all images.)
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localized beneath the vaginal epithelium and mainly sur-
rounded blood vessels (Fig. 2AeH). In the control group, theVIP-ir appeared as an intact ring surrounding the blood ves-
sels; VIP-positive neurons and fibers could be detected
(Fig. 2A). The VIP expression was different in each group of
Fig. 2. The distribution of vasoactive intestinal peptide (VIP) in the subepithelial connective tissue of the anterior vaginal wall cross-sections from an asymptomatic
control and from patients with pelvic organ prolapse (POP) with or without stress urinary incontinence (SUI) (A) In the control group, VIP-immunoreactive (VIP-
ir) nerves appear as an intact ring surrounding blood vessels. (B) In POP I, VIP-ir nerves, which are localized around the thicken arteries, show continuous dark
brown beading changes. The VIP-ir nerves have a dispersed and weakly stained pattern in (C) POP II and in (D) POP III. (F) In POP II þ SUI, the VIP-ir nerves are
more weakly stained in comparison to the nerves in (C) POP II. (E) In POP IV, (G) POP III þ SUI, and (H) POP IV þ SUI, only a few scattered VIP-ir nerves with
weak staining are present. (The scale bar ¼ 100 mm. VIP immunohistochemistry plus hematoxylin used in all images.)
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arteries with numerous dark brown particles found in beads
(Fig. 2B). However, in POP II and POP III (Fig. 2C and D,
respectively), the intensity and distribution of VIP-ir decreased
and showed disperse and weak staining. In POP IV, POP
III þ SUI, and POP IV þ SUI (Fig. 2E, G and H,respectively), only scattered VIP-ir with weak staining was
observed. Table 2 shows the results of the semi-quantitative
analysis. With the progression of POP symptoms, the VIP
innervation in the anterior vaginal epithelium was significantly
downregulated. The intensity of VIP-ir in the eight groups was
as follows (in decreasing order of intensity): control; POP I;
Table 2
Assessment of VIP-ir and staining density in the anterior vaginal wall of POP
patients.
Group Case e Staining Density
þ þþ þþþ
Control 9 0 0 2 7
POPI 8 0 0 5 3
POPII 10 3 6 1 0
POPIII 15 8 6 1 0
POPIV 8 6 2 0 0
POPII þ SUI 7 3 4 0 0
POPIII þ SUI 6 5 1 0 0
POPIV þ SUI 5 4 1 0 0
POP ¼ pelvic organ prolapse; SUI ¼ stress urinary incontinence;
VIP ¼ vasoactive intestinal peptide; VIP-ir ¼ VIP-immunoreactivity.
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and POP IV þ SUI. The intensity of VIP-ir was considerably
weaker and similar in the POP IV, POP III þ SUI, and POP
IV þ SUI groups (Table 2).VIP levels in the vaginal tissues of the anterior wall of
patients with POPThe level of VIP protein in the vaginal tissues of the
anterior wall was measured in all control and POP groups.Fig. 3. The level of vasoactive intestinal peptide (VIP) in the anterior vaginal
wall of women with pelvic organ prolapse (POP) with or without stress urinary
incontinence (SUI). Tissue of the anterior vaginal wall from symptomatic
control subjects, and from patients with POP I, POP II, POP II þ SUI, POP III,
POP III þ SUI, POP IV, and POP IV þ SUI were extracted and analyzed by
Western blotting assay (upper blot image). The semiquantitative change in the
VIP level, corresponding to the b-actin level in the POP groups, is determined
by optical density measurements (lower blot image). The bar graph shows the
average of three experiments  SD. The control is expressed as 100%. The
VIP level is significantly reduces with increasing severity of POP with or
without SUI. In the same grade of POP, there is no significant difference
between the POP and POP þ SUI subgroups in the VIP level. POP-Q ¼ pelvic
organ prolapse quantification; SD ¼ standard deviation. ap < 0.05, compared
to control. bp < 0.05, compared to POPI. cp < 0.05, compared to POPII.
dp < 0.05, compared to POPIII.Fig. 3 shows the results. There was obvious expression of VIP
in the control group. With the progression of POP symptoms,
the level of VIP decreased significantly. Semi-quantitative
analysis showed that the level of VIP protein in vaginal tis-
sue was 89%  7.2% in POP I; 76%  6.3% in POP II;
71%  6.9% in POP II þ SUI; 25%  4.1% in POP III;
23%  6.9% in POP III þ SUI; 14%  3.5% in POP IV; and
11%  3.5% in POP IV þ SUI. The significantly different
levels of VIP in the eight groups were as follows (in
decreasing order): control; POP I; POP II and POP II þ SUI;
POP III and POP III þ SUI; POP IV and POP IV þ SUI. For
all comparisons, p < 0.05 (Fig. 3).
Discussion
In the present study, we hypothesized that, in addition to the
mechanical stress on the pelvic floor, some women have dif-
ferences in VIP innervation that predispose them to POP.
Therefore, we undertook an analysis to assess VIP innervation
in the vaginal epithelium of 70 postmenopausal women. The
results showed that the expression of VIP-ir neurons and fibers
decreased significantly with the progression of POP symptoms.
From our random samples, the proportion of POP com-
bined with SUI was as follows: POP II, 69% (11/16); POP III,
43% (6/14); and POP IV, 60% (9/15); these results are
consistent with a previous study [15]. In the human female
genital tract, peptide-containing nerve fibers exist near blood
vessels and smooth muscles and the fibers line the epithelium
[6,16e18]. Epidemiologic data have suggested that disruption
in the innervation of the pelvic floor, including dysregulation
of VIP, may be an important factor in the etiology of SUI and
POP [19e22]. Some reports have also shown age-related
changes in VIP levels in patients with POP [7,13]. Our pre-
sent study further supports these results, indicating that
decreased VIP innervation of the anterior vaginal epithelium is
associated with the severity of POP with or without SUI.
Our results show that the expression of VIP in the vaginal
epithelium decreased significantly in the POP II þ SUI and the
POP III þ SUI groups, compared to the corresponding groups
without SUI. These results are consistent with previous studies
showing that the expression of neuropeptide Y (NPY) was
significantly reduced in the epithelium of the posterior vaginal
wall in women with SUI [13]. The lower VIP-ir in patients with
SUI may either be related to the lower neuronal production of
VIP [13] or to age-induced nerve degeneration [7]. In the
present study, the expression of VIP in the epithelium was
reduced because of the decreased production of VIP, as indi-
cated by our WB data, which proved that the VIP level in the
same tissue was reduced in POP patients with or without SUI.
Our WB data were consistent with previous studies showing
that VIP levels were significantly decreased in the anterior
vaginal wall of premenopausal and postmenopausal patients
with SUI or POP. Furthermore, those studies found that VIP
levels were inversely correlated with age and menopausal status
in patients with SUI or POP [23]. Our results showed that VIP
expression and VIP levels in the anterior vaginal epithelium
were reduced with increased severity of POP with or without
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another study has shown that VIP expression has no correlation
with age or menopausal status in patients with SUI, but is
negatively correlated with age and menopausal status in pa-
tients with POP [13]. These results suggest that the role of VIP
innervation in POP may be different from its role in SUI.
Vasoactive intestinal peptide is a neurotransmitter in the
vasculature of the genitalia. It has been suggested that the
endogenous neurotransmitter mediating genital blood flowmay
be a substrate for VIP [24]. Our data further confirm that VIP
innervation occurs mainly near blood vessels located beneath
the vaginal epithelium. With increasing severity of POP (with
or without SUI), the distribution of VIP-ir particles changed
from a circle that surrounded the vessel wall to particles that
were scattered along the vessel wall.
The present data did not show significant differences be-
tween POP IV and POP IV þ SUI groups in VIP innervation
or in the VIP level in the anterior vaginal epithelium. As our
HE data show, pathological changes such as lamina propria
tissue breakdown and loss of a considerable number of cells
in the vaginal epithelium were most severe in these two
groups. There was only scattered VIP-ir expression with
weak staining in the POP IV and the POP IV þ SUI groups.
It was difficult to analyze the significance of differences
between the two groups in with such low VIP expression. A
previous study has demonstrated that the denervation of the
vaginal epithelium provides a barrier to compensatory
remodeling and repair in this situation [25,26]. Because the
number of samples was limited, the present investigation has
not explicitly proven that the proportion of POP cases
accompanied by SUI is correlated with the severity of POP
disease. Therefore, we should expand our sample size and
gain more evidence.
In summary, the present study constituted the most defini-
tive assessment of the relationship between VIP expression
and the POP-Q score. The present data could not determine
whether differences in VIP innervation are the cause of POP or
whether they result from the pathological changes caused by
POP. Further studies are needed in an animal model to
investigate whether manipulating VIP levels in vaginal tissue
could interfere with the progression of POP. Such analyses
would give additional insights into what experiments are
needed to confirm the relationship between VIP and the POP-
Q score indicated in the present study.Acknowledgments
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